{"id": "article-31438_0", "title": "Juvenile Xanthogranuloma  -- Continuing Education Activity", "content": "Juvenile xanthogranuloma (JXG) is a non-Langerhans cell histiocytosis and is fairly common, often affecting infants and young children. Cutaneous lesions usually resolve spontaneously and most patients have an unremarkable course. Ocular JXG can occur and has an increased incidence in those 2 years of age or younger or in those with multiple lesions. Ocular involvement can be associated with many potential complications including blindness. There is an association of JXG with juvenile myelomonocytic leukemia and neurofibromatosis type 1 (NF1).", "contents": "Juvenile Xanthogranuloma  -- Continuing Education Activity. Juvenile xanthogranuloma (JXG) is a non-Langerhans cell histiocytosis and is fairly common, often affecting infants and young children. Cutaneous lesions usually resolve spontaneously and most patients have an unremarkable course. Ocular JXG can occur and has an increased incidence in those 2 years of age or younger or in those with multiple lesions. Ocular involvement can be associated with many potential complications including blindness. There is an association of JXG with juvenile myelomonocytic leukemia and neurofibromatosis type 1 (NF1)."}
{"id": "article-31438_1", "title": "Juvenile Xanthogranuloma  -- Continuing Education Activity", "content": "Objectives: Outline the risk factors for xanthogranulomas. Describe the typical presentation of a patient with a xanthogranuloma. Review the pathophysiology of xanthogranulomas. Explain interprofessional team strategies for improving care coordination and communication regarding the management of patients with xanthogranulomas. Access free multiple choice questions on this topic.", "contents": "Juvenile Xanthogranuloma  -- Continuing Education Activity. Objectives: Outline the risk factors for xanthogranulomas. Describe the typical presentation of a patient with a xanthogranuloma. Review the pathophysiology of xanthogranulomas. Explain interprofessional team strategies for improving care coordination and communication regarding the management of patients with xanthogranulomas. Access free multiple choice questions on this topic."}
{"id": "article-31438_2", "title": "Juvenile Xanthogranuloma  -- Introduction", "content": "Juvenile xanthogranuloma (JXG) is a\u00a0relatively\u00a0common\u00a0entity\u00a0and is the most common form of non-Langerhans cell histiocytic\u00a0disorder of childhood. [1] , [2] It is estimated that in\u00a075% of cases, lesions appear during the first year of life, with >15-20% of patients having\u00a0lesions at birth.\u00a0JXG is rare in adults,\u00a0with a\u00a0peak incidence in the late twenties to thirties. Rarely, reports exist of lesions arising in the elderly.\u00a0The majority of adult patients have solitary lesions. [3] The true incidence, however, may be underestimated, as many lesions, especially those which are solitary and small (up to 90% of all patients), may go unrecognized.\u00a0Typically, the clinical presentation consists of solitary or multiple yellow-orange-brown firm papules or\u00a0nodules. The most common locations are the face, neck, and upper torso. [3] Oral lesions are rare and often occur as a yellow nodule on the lateral aspects of the tongue. Oral lesions can also arise on the gingival, buccal mucosa, and midline hard palate and may ulcerate and bleed. Lesions of the oral mucosa may appear verrucous, umbilicated,\u00a0pedunculated, or fibroma-like. Cutaneous lesions are usually asymptomatic, and most lesions spontaneously involute over the course of several years. Although occurring rarely, ocular involvement is the most common extracutaneous site involved, followed by the lungs. Ocular JXG is\u00a0nearly always unilateral and develops in less than 0.5% of patients. Approximately 40% of patients with ocular JXG, however, have multiple cutaneous lesions at the time of diagnosis. Ocular\u00a0disease usually occurs\u00a0prior to 2 years of age and commonly affects the iris. Hyphema and glaucoma are serious complications that can result in blindness and necessitate early referral to an ophthalmologist for evaluation and possible treatment. Other bone, visceral and or CNS involvement (e.g. diabetes insipidus) is unusual. Disease-related deaths are rare. [1]", "contents": "Juvenile Xanthogranuloma  -- Introduction. Juvenile xanthogranuloma (JXG) is a\u00a0relatively\u00a0common\u00a0entity\u00a0and is the most common form of non-Langerhans cell histiocytic\u00a0disorder of childhood. [1] , [2] It is estimated that in\u00a075% of cases, lesions appear during the first year of life, with >15-20% of patients having\u00a0lesions at birth.\u00a0JXG is rare in adults,\u00a0with a\u00a0peak incidence in the late twenties to thirties. Rarely, reports exist of lesions arising in the elderly.\u00a0The majority of adult patients have solitary lesions. [3] The true incidence, however, may be underestimated, as many lesions, especially those which are solitary and small (up to 90% of all patients), may go unrecognized.\u00a0Typically, the clinical presentation consists of solitary or multiple yellow-orange-brown firm papules or\u00a0nodules. The most common locations are the face, neck, and upper torso. [3] Oral lesions are rare and often occur as a yellow nodule on the lateral aspects of the tongue. Oral lesions can also arise on the gingival, buccal mucosa, and midline hard palate and may ulcerate and bleed. Lesions of the oral mucosa may appear verrucous, umbilicated,\u00a0pedunculated, or fibroma-like. Cutaneous lesions are usually asymptomatic, and most lesions spontaneously involute over the course of several years. Although occurring rarely, ocular involvement is the most common extracutaneous site involved, followed by the lungs. Ocular JXG is\u00a0nearly always unilateral and develops in less than 0.5% of patients. Approximately 40% of patients with ocular JXG, however, have multiple cutaneous lesions at the time of diagnosis. Ocular\u00a0disease usually occurs\u00a0prior to 2 years of age and commonly affects the iris. Hyphema and glaucoma are serious complications that can result in blindness and necessitate early referral to an ophthalmologist for evaluation and possible treatment. Other bone, visceral and or CNS involvement (e.g. diabetes insipidus) is unusual. Disease-related deaths are rare. [1]"}
{"id": "article-31438_3", "title": "Juvenile Xanthogranuloma  -- Introduction", "content": "As opposed to other xanthomatous diseases, juvenile xanthogranulomas are not associated with metabolic or lipid disorders. [3]", "contents": "Juvenile Xanthogranuloma  -- Introduction. As opposed to other xanthomatous diseases, juvenile xanthogranulomas are not associated with metabolic or lipid disorders. [3]"}
{"id": "article-31438_4", "title": "Juvenile Xanthogranuloma  -- Etiology", "content": "It is presumed that\u00a0juvenile xanthogranulomas develop after unknown stimuli (infectious or physical) and provoke a granulomatous histiocytic reaction. [3] However, the true etiology of juvenile xanthogranuloma is currently\u00a0unknown, and conservative management is generally advised. [4]", "contents": "Juvenile Xanthogranuloma  -- Etiology. It is presumed that\u00a0juvenile xanthogranulomas develop after unknown stimuli (infectious or physical) and provoke a granulomatous histiocytic reaction. [3] However, the true etiology of juvenile xanthogranuloma is currently\u00a0unknown, and conservative management is generally advised. [4]"}
{"id": "article-31438_5", "title": "Juvenile Xanthogranuloma  -- Etiology", "content": "Juvenile xanthogranulomas have been associated with juvenile chronic myelogenous leukemia (JMML). [5] Juvenile myelomonocytic leukemia (JMML) is also seen in patients with neurofibromatosis (the incidence is between 1:2000 and 1:5000). Rarely, it is seen in patients with both juvenile xanthogranuloma and neurofibromatosis. [4] However, when this does occur, these children have a 20- to 32-fold increased risk of juvenile myelomonocytic leukemia when compared to patients with neurofibromatosis alone. [6]", "contents": "Juvenile Xanthogranuloma  -- Etiology. Juvenile xanthogranulomas have been associated with juvenile chronic myelogenous leukemia (JMML). [5] Juvenile myelomonocytic leukemia (JMML) is also seen in patients with neurofibromatosis (the incidence is between 1:2000 and 1:5000). Rarely, it is seen in patients with both juvenile xanthogranuloma and neurofibromatosis. [4] However, when this does occur, these children have a 20- to 32-fold increased risk of juvenile myelomonocytic leukemia when compared to patients with neurofibromatosis alone. [6]"}
{"id": "article-31438_6", "title": "Juvenile Xanthogranuloma  -- Etiology", "content": "Other diseases associated with juvenile xanthogranuloma include\u00a0the following: urticaria pigmentosa, insulin-dependent diabetes mellitus, aquagenic pruritis, and even cytomegalovirus (CMV) infection. [5]", "contents": "Juvenile Xanthogranuloma  -- Etiology. Other diseases associated with juvenile xanthogranuloma include\u00a0the following: urticaria pigmentosa, insulin-dependent diabetes mellitus, aquagenic pruritis, and even cytomegalovirus (CMV) infection. [5]"}
{"id": "article-31438_7", "title": "Juvenile Xanthogranuloma  -- Epidemiology", "content": "Juvenile xanthogranulomas are most commonly found in early childhood with >15-20% of patients having\u00a0lesions at birth.\u00a0It is estimated that in\u00a075% of cases, lesions appear during the first year of life. [1] Approximately 10% of cases may appear in adulthood and are known as adult xanthogranulo ma . [1] In children, the disease most often affects males; however, in adults, there is no sex prevalence. [3]", "contents": "Juvenile Xanthogranuloma  -- Epidemiology. Juvenile xanthogranulomas are most commonly found in early childhood with >15-20% of patients having\u00a0lesions at birth.\u00a0It is estimated that in\u00a075% of cases, lesions appear during the first year of life. [1] Approximately 10% of cases may appear in adulthood and are known as adult xanthogranulo ma . [1] In children, the disease most often affects males; however, in adults, there is no sex prevalence. [3]"}
{"id": "article-31438_8", "title": "Juvenile Xanthogranuloma  -- Histopathology", "content": "Juvenile xanthogranulomas occur most commonly in the skin and show a characteristic morphology. The lesions exhibit a well-demarcated, dense invasion of numerous histiocytes within the superficial dermis and blunting of the rete ridges along with scattered lymphocytes, plasma cells and eosinophils. [1] Of note, the mononuclear cells may show a spindled or elongated appearance. [5] Foam cells, foreign body giant cells, and Touton giant cells may be seen in the mature stage. [1] The characteristic multinucleated giant cell (Touton cell) is observed in 85% of juvenile xanthogranulomas, and these\u00a0appear garland-like . [3] [1] At the late stage of the lesion, fibroblasts are increased, and fibrosis replaces the infiltration. [1] In ocular involvement, the tumor cells have abundant cytoplasm and show decreased numbers of Touton cells as compared to cutaneous juvenile xanthogranulomas. [1]", "contents": "Juvenile Xanthogranuloma  -- Histopathology. Juvenile xanthogranulomas occur most commonly in the skin and show a characteristic morphology. The lesions exhibit a well-demarcated, dense invasion of numerous histiocytes within the superficial dermis and blunting of the rete ridges along with scattered lymphocytes, plasma cells and eosinophils. [1] Of note, the mononuclear cells may show a spindled or elongated appearance. [5] Foam cells, foreign body giant cells, and Touton giant cells may be seen in the mature stage. [1] The characteristic multinucleated giant cell (Touton cell) is observed in 85% of juvenile xanthogranulomas, and these\u00a0appear garland-like . [3] [1] At the late stage of the lesion, fibroblasts are increased, and fibrosis replaces the infiltration. [1] In ocular involvement, the tumor cells have abundant cytoplasm and show decreased numbers of Touton cells as compared to cutaneous juvenile xanthogranulomas. [1]"}
{"id": "article-31438_9", "title": "Juvenile Xanthogranuloma  -- Histopathology", "content": "Lesions of juvenile xanthogranuloma classically stain with the following markers: CD68 or Ki-M1P and anti F XIIIa, vimentin, and anti-CD4. [1]", "contents": "Juvenile Xanthogranuloma  -- Histopathology. Lesions of juvenile xanthogranuloma classically stain with the following markers: CD68 or Ki-M1P and anti F XIIIa, vimentin, and anti-CD4. [1]"}
{"id": "article-31438_10", "title": "Juvenile Xanthogranuloma  -- History and Physical", "content": "Juvenile xanthogranuloma generally\u00a0occurs in two forms. [7] The first form is composed of multiple 2 to 5 millimeter dome-shaped papules that take on a pink to reddish brown hue and, subsequently, turn yellow. [7] The second form is composed of one or more large nodules which measure 1 to 2 centimeters. [7] Other variants and presentations include giant juvenile xanthogranuloma, atrophic plaque, cutaneous horn, and subcutaneous mass. [7]", "contents": "Juvenile Xanthogranuloma  -- History and Physical. Juvenile xanthogranuloma generally\u00a0occurs in two forms. [7] The first form is composed of multiple 2 to 5 millimeter dome-shaped papules that take on a pink to reddish brown hue and, subsequently, turn yellow. [7] The second form is composed of one or more large nodules which measure 1 to 2 centimeters. [7] Other variants and presentations include giant juvenile xanthogranuloma, atrophic plaque, cutaneous horn, and subcutaneous mass. [7]"}
{"id": "article-31438_11", "title": "Juvenile Xanthogranuloma  -- History and Physical", "content": "Serious complications can arise when systemic juvenile xanthogranulomas develop. Systemic juvenile xanthogranulomas develop in 4% of children, with an overall mortality of 5% to 10%. [6] Fatalities are usually due to progressive central nervous system (CNS) disease or liver failure. [6] Extracutaneous juvenile xanthogranulomas most commonly affect the eye, and ocular involvement has been seen in 0.3% to 10% of children with cutaneous juvenile xanthogranulomas. [1] Most patients with eye lesions are young children (less than 1 year). [3] The iris is most commonly involved, and complications can arise that lead to\u00a0spontaneous intraocular hemorrhages, glaucoma, and even blinding eye disease. [1] Of importance, spontaneous hyphema with or without increase of intraocular pressure is a common sign of iris juvenile xanthogranuloma. [8]", "contents": "Juvenile Xanthogranuloma  -- History and Physical. Serious complications can arise when systemic juvenile xanthogranulomas develop. Systemic juvenile xanthogranulomas develop in 4% of children, with an overall mortality of 5% to 10%. [6] Fatalities are usually due to progressive central nervous system (CNS) disease or liver failure. [6] Extracutaneous juvenile xanthogranulomas most commonly affect the eye, and ocular involvement has been seen in 0.3% to 10% of children with cutaneous juvenile xanthogranulomas. [1] Most patients with eye lesions are young children (less than 1 year). [3] The iris is most commonly involved, and complications can arise that lead to\u00a0spontaneous intraocular hemorrhages, glaucoma, and even blinding eye disease. [1] Of importance, spontaneous hyphema with or without increase of intraocular pressure is a common sign of iris juvenile xanthogranuloma. [8]"}
{"id": "article-31438_12", "title": "Juvenile Xanthogranuloma  -- History and Physical", "content": "Other CNS complications include seizures, increased intracranial pressure, diabetes insipidus, and developmental delay. [6] These extracutaneous lesions may also be seen in the deeper soft tissues, spleen, and lung. [6]", "contents": "Juvenile Xanthogranuloma  -- History and Physical. Other CNS complications include seizures, increased intracranial pressure, diabetes insipidus, and developmental delay. [6] These extracutaneous lesions may also be seen in the deeper soft tissues, spleen, and lung. [6]"}
{"id": "article-31438_13", "title": "Juvenile Xanthogranuloma  -- Evaluation", "content": "Dermoscopy is a noninvasive technique used as an aid in the diagnosis of juvenile xanthogranuloma.\u00a0It\u00a0shows a characteristic setting su n\u00a0appearance (red-yellow center and discrete erythematous halo).\u00a0Complete removal via surgical excision gives diagnostic confirmation. [2]", "contents": "Juvenile Xanthogranuloma  -- Evaluation. Dermoscopy is a noninvasive technique used as an aid in the diagnosis of juvenile xanthogranuloma.\u00a0It\u00a0shows a characteristic setting su n\u00a0appearance (red-yellow center and discrete erythematous halo).\u00a0Complete removal via surgical excision gives diagnostic confirmation. [2]"}
{"id": "article-31438_14", "title": "Juvenile Xanthogranuloma  -- Treatment / Management", "content": "Curative skin excisions may be performed in easily accessible sites; however, most lesions in childhood spontaneously involute and require no therapy. [6]", "contents": "Juvenile Xanthogranuloma  -- Treatment / Management. Curative skin excisions may be performed in easily accessible sites; however, most lesions in childhood spontaneously involute and require no therapy. [6]"}
{"id": "article-31438_15", "title": "Juvenile Xanthogranuloma  -- Treatment / Management", "content": "Management of non-cutaneous (internal) lesions poses greater difficulty and may include any combination of surgery, chemotherapy, radiotherapy, and immunosuppression. [3] In general, chemotherapy and radiotherapy are options for the patient with symptomatic, unresectable, or incompletely resected extracutaneous disease. [4] Patients with concurrent neurofibromatosis type 1 (NF-1) should receive frequent followup with a complete blood count to monitor for juvenile chronic myelogenous leukemia (JMML). [6]", "contents": "Juvenile Xanthogranuloma  -- Treatment / Management. Management of non-cutaneous (internal) lesions poses greater difficulty and may include any combination of surgery, chemotherapy, radiotherapy, and immunosuppression. [3] In general, chemotherapy and radiotherapy are options for the patient with symptomatic, unresectable, or incompletely resected extracutaneous disease. [4] Patients with concurrent neurofibromatosis type 1 (NF-1) should receive frequent followup with a complete blood count to monitor for juvenile chronic myelogenous leukemia (JMML). [6]"}
{"id": "article-31438_16", "title": "Juvenile Xanthogranuloma  -- Treatment / Management", "content": "Eye exams are recommended for high-risk patients. Topical, intralesional, and subconjunctival corticosteroids may be administered for ocular involvement.\u00a0If complications arise (i.e., glaucoma or hyphema), surgery or systemic steroids may be required. [6]", "contents": "Juvenile Xanthogranuloma  -- Treatment / Management. Eye exams are recommended for high-risk patients. Topical, intralesional, and subconjunctival corticosteroids may be administered for ocular involvement.\u00a0If complications arise (i.e., glaucoma or hyphema), surgery or systemic steroids may be required. [6]"}
{"id": "article-31438_17", "title": "Juvenile Xanthogranuloma  -- Differential Diagnosis", "content": "The differential of juvenile xanthogranuloma includes both benign and malignant entities, depending on the clinical presentation and site of involvement.", "contents": "Juvenile Xanthogranuloma  -- Differential Diagnosis. The differential of juvenile xanthogranuloma includes both benign and malignant entities, depending on the clinical presentation and site of involvement."}
{"id": "article-31438_18", "title": "Juvenile Xanthogranuloma  -- Differential Diagnosis", "content": "One of the main differential diagnoses of juvenile xanthogranuloma is Langerhans cell histiocytosis (both may exhibit eosinophils). Helpful morphologic features for Langerhans cell histiocytosis (LCH) are grooved vesicular nuclei with a coffee bean \" appearance. [9] Additionally,\u00a0immunohistochemistry shows that the cells of LCH are positive for CD1a and S-100, whereas the cells of juvenile xanthogranuloma are negative for CD1a and S-100. [9] Recall that CD1a is a fairly specific marker for Langerhans cell histiocytosis, and this marker is not expressed in non-LCH diseases. [1]", "contents": "Juvenile Xanthogranuloma  -- Differential Diagnosis. One of the main differential diagnoses of juvenile xanthogranuloma is Langerhans cell histiocytosis (both may exhibit eosinophils). Helpful morphologic features for Langerhans cell histiocytosis (LCH) are grooved vesicular nuclei with a coffee bean \" appearance. [9] Additionally,\u00a0immunohistochemistry shows that the cells of LCH are positive for CD1a and S-100, whereas the cells of juvenile xanthogranuloma are negative for CD1a and S-100. [9] Recall that CD1a is a fairly specific marker for Langerhans cell histiocytosis, and this marker is not expressed in non-LCH diseases. [1]"}
{"id": "article-31438_19", "title": "Juvenile Xanthogranuloma  -- Differential Diagnosis", "content": "Reticulohistiocytoma (another non-LCH histiocytic disorder) has a histologic appearance similar to juvenile xanthogranuloma. [9] This lesion demonstrates large mononucleated or multinucleated histiocytes with a lymphocytic infiltrate and dermal fibrosis. [9] Although positive for CD68, these are negative for vimentin (unlike juvenile xanthogranuloma). [9]", "contents": "Juvenile Xanthogranuloma  -- Differential Diagnosis. Reticulohistiocytoma (another non-LCH histiocytic disorder) has a histologic appearance similar to juvenile xanthogranuloma. [9] This lesion demonstrates large mononucleated or multinucleated histiocytes with a lymphocytic infiltrate and dermal fibrosis. [9] Although positive for CD68, these are negative for vimentin (unlike juvenile xanthogranuloma). [9]"}
{"id": "article-31438_20", "title": "Juvenile Xanthogranuloma  -- Differential Diagnosis", "content": "Although juvenile xanthogranulomas may be found in uncommon locations (i.e., vulva), it is important to remember that other entities (such as embryonal rhabdomyosarcoma) may have a similar histologic appearance and should be ruled out. [9] The morphologic appearance of monomorphic small round cells with a cambium layer and necrosis would help direct to a malignant diagnosis in such cases. [9] Other considerations for the differential diagnosis include other xanthomatous lesions, mastocytomas, dermatofibromas, and Spitz nevus. [4]", "contents": "Juvenile Xanthogranuloma  -- Differential Diagnosis. Although juvenile xanthogranulomas may be found in uncommon locations (i.e., vulva), it is important to remember that other entities (such as embryonal rhabdomyosarcoma) may have a similar histologic appearance and should be ruled out. [9] The morphologic appearance of monomorphic small round cells with a cambium layer and necrosis would help direct to a malignant diagnosis in such cases. [9] Other considerations for the differential diagnosis include other xanthomatous lesions, mastocytomas, dermatofibromas, and Spitz nevus. [4]"}
{"id": "article-31438_21", "title": "Juvenile Xanthogranuloma  -- Prognosis", "content": "The prognosis of juvenile xanthogranuloma is generally\u00a0excellent with most lesions undergoing spontaneous involution over the course of 3-6 years. Lesions which are of cosmetic concern or pose a risk to vital functions can be treated. [6]", "contents": "Juvenile Xanthogranuloma  -- Prognosis. The prognosis of juvenile xanthogranuloma is generally\u00a0excellent with most lesions undergoing spontaneous involution over the course of 3-6 years. Lesions which are of cosmetic concern or pose a risk to vital functions can be treated. [6]"}
{"id": "article-31438_22", "title": "Juvenile Xanthogranuloma  -- Complications", "content": "There are often minimal to no complications of JXG due to its self-limiting nature. Occasionally, lesions are removed for cosmetic concerns. Ocular lesions often require intervention\u00a0to avoid potential complications of blindness, glaucoma or hyphema.", "contents": "Juvenile Xanthogranuloma  -- Complications. There are often minimal to no complications of JXG due to its self-limiting nature. Occasionally, lesions are removed for cosmetic concerns. Ocular lesions often require intervention\u00a0to avoid potential complications of blindness, glaucoma or hyphema."}
{"id": "article-31438_23", "title": "Juvenile Xanthogranuloma  -- Consultations", "content": "Ophthalmology", "contents": "Juvenile Xanthogranuloma  -- Consultations. Ophthalmology"}
{"id": "article-31438_24", "title": "Juvenile Xanthogranuloma  -- Pearls and Other Issues", "content": "Isolated intracranial lesions of juvenile xanthogranuloma have been shown to carry a more favorable prognosis (as opposed to other examples of systemic disease).\u00a0These lesions have been reported to have a BRAF V600E mutation akin to Langerhans cell histiocytosis and Erdheim-Chester disease. However, further study with a larger patient population is necessary to interpret these findings. [10]", "contents": "Juvenile Xanthogranuloma  -- Pearls and Other Issues. Isolated intracranial lesions of juvenile xanthogranuloma have been shown to carry a more favorable prognosis (as opposed to other examples of systemic disease).\u00a0These lesions have been reported to have a BRAF V600E mutation akin to Langerhans cell histiocytosis and Erdheim-Chester disease. However, further study with a larger patient population is necessary to interpret these findings. [10]"}
{"id": "article-31438_25", "title": "Juvenile Xanthogranuloma  -- Enhancing Healthcare Team Outcomes", "content": "The management of solitary lesions of juvenile xanthogranuloma is often straightforward with routine observation. When multiple lesions are present and or there is the involvement of vital structures, management is best\u00a0accomplished\u00a0with an interprofessional team. While skin lesions can be excised, those occurring in other parts of the body may cause compression or obstruction of vital tissues.\u00a0The outcomes for patients with skin-only lesions is\u00a0favorable\u00a0but those with lesions in the\u00a0CNS may suffer from complications of surgery. [11] [12] [13] (Level V)", "contents": "Juvenile Xanthogranuloma  -- Enhancing Healthcare Team Outcomes. The management of solitary lesions of juvenile xanthogranuloma is often straightforward with routine observation. When multiple lesions are present and or there is the involvement of vital structures, management is best\u00a0accomplished\u00a0with an interprofessional team. While skin lesions can be excised, those occurring in other parts of the body may cause compression or obstruction of vital tissues.\u00a0The outcomes for patients with skin-only lesions is\u00a0favorable\u00a0but those with lesions in the\u00a0CNS may suffer from complications of surgery. [11] [12] [13] (Level V)"}
{"id": "article-31438_26", "title": "Juvenile Xanthogranuloma  -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Juvenile Xanthogranuloma  -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}